Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Peng Hou

机构:Nanjing University of Chinese Medicine, China National Bamboo Research Center, First Affiliated Hospital of Xi'an Jiaotong University · ORCID:0000-0001-7010-7944

发表论文 216 篇 · 总被引 7423 次 · h-index 45

代表论文

  • Disulfiram/copper triggers cGAS-STING innate immunity pathway via ROS-induced DNA damage that potentiates antitumor response to PD-1 checkpoint blockade (2025 · International Journal of Biological Sciences · 被引 18)
  • Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide–Drug Conjugates (2024 · Journal of Medicinal Chemistry · 被引 18)
  • Genome-wide CRISPR screening identifies PHF8 as an effective therapeutic target for KRAS- or BRAF-mutant colorectal cancers (2025 · Journal of Experimental & Clinical Cancer Research · 被引 12)
  • Penfluridol enhances anti-tumor immunity in colorectal cancer by inducing proteasome-mediated degradation of PD-L1 via the activation of AMPK (2025 · Translational Oncology · 被引 7)
  • Thyrotropin exacerbates insulin resistance by triggering macrophage inflammation in subclinical hypothyroidism (2025 · Experimental & Molecular Medicine · 被引 7)
  • Single-cell RNA sequencing integrated with bulk RNA sequencing analysis of clock circadian regulator with prognostic and immune microenvironment in thyroid cancer (2025 · Translational Oncology · 被引 5)